Biotech giant Bavarian Nordic sees share price spike on the back of HPV vaccine deal

The Danish company will receive 171 million dollars from Johnson and Johnson subsidiary

The share price of the Danish biotech company Bavarian Nordic has shot up by 6 percent following the announcement that the company has signed a licence and collaboration deal worth 171 million dollars with Janssen Pharmaceuticals, a division of Johnson and Johnson.

The deal will give Janssen exclusive rights to Bavarian Nordic’s MVA-BN vaccine in the treatment of human papillomavirus (HPV). The product will be combined with Janssen’s AdVac technology in the treatment of all cancers induced by HPV.

CEO: Potential to transform treatment paradigm
Paul Chaplin, the head of Bavarian Nordic, sees great potential in the collaboration.

“We are excited to expand our collaboration with Janssen on the evaluation of MVA-BN as a therapeutic approach to HPV, which represents a significant opportunity to transform the treatment paradigm in cervical and other cancers induced by the virus,“ he said.

“Through the ongoing collaboration on Ebola, we have already made significant advances with our MVA-BN technology, demonstrating its potential to enhance and prolong immune responses induced by Janssen’s AdVac technology, and we look forward to expanding the partnership to explore the same concept for HPV.”

Bavarian Nordic has had an exceptional year, with its share price increasing by more than 70 percent since January.

TOP STORIES

  • Danish Intelligence Service: Threat from Russia has intensified

    Danish Intelligence Service: Threat from Russia has intensified

    In the internal Danish waters, Russia will be able to attack underwater infrastructure from all types of vessels. The target could be cables with data, electricity and gas, assesses the Danish Defense Intelligence Service

  • Denmark to explore screening citizenship applicants for anti-democratic sentiments

    Denmark to explore screening citizenship applicants for anti-democratic sentiments

    A few weeks after Alex Vanopslagh’s comments about “right values,” the government announced that an expert committee would be established to examine the feasibility of screening citizenship applicants for anti-democratic attitudes.

  • The Future Copenhagen

    The Future Copenhagen

    The municipality plan encompasses building 40,000 houses by 2036 in order to help drive real estate prices down. But this is not the only huge project that will change the shape of the city: Lynetteholmen, M5 metro line, the Eastern Ring Road, and Jernbanebyen will transform Copenhagen into something different from what we know today

  • It’s not you: winter depression is affecting many people

    It’s not you: winter depression is affecting many people

    Many people in Denmark are facing hard times marked by sadness, anxiety, and apathy. It’s called winter depression, and it’s a widespread phenomenon during the cold months in Nordic countries.

  • Crime rates are rising, but people are safer

    Crime rates are rising, but people are safer

    Crime in Denmark is increasing for the second consecutive year, but it is more focused on property, while people appear to be safer than before. Over the past year, there were fewer incidents of violence

  • Novo Nordisk invests 8.5 billion DKK in new Odense facility

    Novo Nordisk invests 8.5 billion DKK in new Odense facility

    Despite Novo’s announcement that its growth abroad will be larger than in Denmark, the company announced this morning an 8.5 billion DKK investment for a new facility in Odense. This is the first time the company has established a new production site in Denmark this century.

Connect club

Connect Club is your gateway to a vibrant programme of events and an international community in Denmark.

Sign up here

Career

Want to advertise your job with CPH Post?

Contact us

Jobs